Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation

Tissue injury caused by infection or physical damage evokes inflammatory reactions and events that are necessary for regaining homeostasis. Central to these events is the translocation of leukocytes, including monocytes, neutrophils, and T lymphocytes, from the vascular system, through endothelium, and into the extracellular matrix (ECM) surrounding the injured tissue. This transition from the vasculature into the site of inflammation elicits remarkable changes in leukocyte behavior as cells adhere to and migrate across ECM before carrying out their effector functions. Growing evidence suggests that, through its interactions with cytokines and degradative enzymes, the ECM microenvironment has a specialized role in providing intrinsic signals for coordinating leukocyte actions. Recent advances also reveal that enzymatic modifications to ECM moieties and cytokines induce distinctive cellular responses, and are likely part of the mechanism regulating the perpetuation or arrest of inflammation. This article reviews the findings that have elucidated the dynamic relationships among these factors and how they communicate with immune cells during inflammation. J. Leukoc. Biol. 67: 149–159; 2000.

[1]  D. Cerretti Characterization of the tumour necrosis factor α-converting enzyme, TACE/ADAM17 , 1999 .

[2]  Y. Okada,et al.  Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. , 1997, The Biochemical journal.

[3]  E. M. Smith,et al.  Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. , 1990, The Journal of clinical investigation.

[4]  A. Ariel,et al.  IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. , 1998, Journal of immunology.

[5]  E. Campbell,et al.  Elastase and cathepsin G of human monocytes: heterogeneity and subcellular localization to peroxidase-positive granules. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  C. Boudier,et al.  Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. , 1995, Journal of immunology.

[7]  J. Bieth Elastases: Catalytic and Biological Properties , 1986 .

[8]  A. M. Romanic,et al.  The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent , 1994, The Journal of cell biology.

[9]  M. Baggiolini,et al.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Stockley,et al.  A discrete subpopulation of human monocytes expresses a neutrophil-like proinflammatory (P) phenotype. , 1994, The American journal of physiology.

[11]  J. C. Taylor,et al.  Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. , 1977, Biochemistry.

[12]  C. Damsky,et al.  Integrin‐dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane , 1996, Journal of cellular biochemistry.

[13]  A. Ben-Baruch,et al.  Signals and Receptors Involved in Recruitment of Inflammatory Cells (*) , 1995, The Journal of Biological Chemistry.

[14]  G. Murphy,et al.  Metalloproteinase-mediated Regulation of L-selectin Levels on Leucocytes (*) , 1996, The Journal of Biological Chemistry.

[15]  K. Matsuura,et al.  ADAM family proteins in the immune system. , 1999, Immunology today.

[16]  S. Hauser,et al.  Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  C. Nathan,et al.  Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. , 1991, The Journal of biological chemistry.

[18]  S. Rosenberg,et al.  Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.

[19]  T. Haas,et al.  The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[20]  H. Lortat-Jacob,et al.  Interferon-gamma, an anti-fibrogenic cytokine which binds to heparan sulfate. , 1994, Pathology, research and practice.

[21]  M. Ploug,et al.  Cell-surface acceleration of urokinase-catalyzed receptor cleavage. , 1997, European journal of biochemistry.

[22]  R. Hershkoviz,et al.  Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. , 1996, Immunology today.

[23]  Michael V. Doyle,et al.  Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.

[24]  R. Bast,et al.  Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor , 1994, Nature.

[25]  M. Baggiolini,et al.  Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.

[26]  N. Hooper,et al.  Role for ADAM-family proteinases as membrane protein secretases. , 1999, Biochemical Society transactions.

[27]  H. Flad,et al.  Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2. , 1994, Journal of immunology.

[28]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[29]  T. Bjornsson,et al.  Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue‐type and urokinase‐type plasminogen activators , 1993, Journal of cellular physiology.

[30]  F. Sánchez‐Madrid,et al.  Polarization of Chemokine Receptors to the Leading Edge during Lymphocyte Chemotaxis , 1997, The Journal of experimental medicine.

[31]  J. Massagué,et al.  Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors (*) , 1996, The Journal of Biological Chemistry.

[32]  B. Packard,et al.  Mitogenic stimulation of human lymphocytes mediated by a cell surface elastase. , 1995, Biochimica et biophysica acta.

[33]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[34]  F. Maxfield,et al.  Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl- phenylalanine , 1995, The Journal of experimental medicine.

[35]  E. M. Smith,et al.  Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III. , 1990, Journal of Laboratory and Clinical Medicine.

[36]  O. Pappo,et al.  Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis , 1999, Nature Medicine.

[37]  K. Takano,et al.  A 16-kDa fragment of collagen type XIV is a novel neutrophil chemotactic factor purified from rat granulation tissue. , 1999, Biochemical and biophysical research communications.

[38]  D. Adams,et al.  T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. , 1993, Nature.

[39]  E. Goetzl,et al.  Matrix metalloproteinases in immunity. , 1996, Journal of Immunology.

[40]  I. Cohen,et al.  A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity. , 1999, Biochemical and biophysical research communications.

[41]  J. Banchereau,et al.  Human interleukin 4 is a glycosaminoglycan-binding protein. , 1997, Cytokine.

[42]  A. Mauviel Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.

[43]  G. Laurent,et al.  Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. , 1995, American journal of respiratory cell and molecular biology.

[44]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[45]  K. Olczyk,et al.  [Wound repair]. , 1998, Postepy higieny i medycyny doswiadczalnej.

[46]  R. Alon,et al.  TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. , 1994, Journal of immunology.

[47]  P. Negulescu,et al.  Polarity of T cell shape, motility, and sensitivity to antigen. , 1996, Immunity.

[48]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[49]  C. Rüegg,et al.  Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. , 1997, Journal of immunology.

[50]  H. Sabzevari,et al.  Production and regulation of gelatinase B by human T-cells. , 1993, Biochimica et biophysica acta.

[51]  S. Ratner Motility of IL-2-stimulated lymphocytes in neutral and acidified extracellular matrix. , 1992, Cellular immunology.

[52]  M. Baggiolini,et al.  Interleukin‐8 processing by neutrophil elastase, cathepsin G and proteinase‐3 , 1994, FEBS letters.

[53]  H. Chapman,et al.  An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. , 1991, The Journal of clinical investigation.

[54]  R. Hershkoviz,et al.  Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH , 1995, The Journal of experimental medicine.

[55]  Y. Shimizu,et al.  Lymphocyte interactions with extracellular matrix , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[57]  C. Owen,et al.  Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. , 1997, The American journal of physiology.

[58]  Z. Werb,et al.  ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.

[59]  R. Hershkoviz,et al.  Tumour necrosis factor-alpha interacts with laminin and functions as a pro-adhesive cytokine. , 1995, Immunology.

[60]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[61]  F. Mangili,et al.  Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. , 1996, The Journal of clinical investigation.

[62]  M. Nakao,et al.  CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration , 1999, Oncogene.

[63]  A. Kulkarni,et al.  Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[64]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[65]  I. Cohen,et al.  Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix , 1987, Journal of cellular physiology.

[66]  J. McDonald,et al.  Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. , 1980, The Journal of biological chemistry.

[67]  Kenneth M. Yamada,et al.  Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix‐bound interleukin‐7 , 1997, European journal of immunology.

[68]  D. Adams,et al.  T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ , 1993, Nature.

[69]  W. Cowden,et al.  Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. , 1999, Cancer research.

[70]  W. Howe,et al.  CXC Chemokines Connective Tissue Activating Peptide-III and Neutrophil Activating Peptide-2 are Heparin/Heparan Sulfate-degrading Enzymes (*) , 1995, The Journal of Biological Chemistry.

[71]  D. Adams,et al.  Leucocyte-endothelial interactions and regulation of leucocyte migration , 1994, The Lancet.

[72]  P. Bohlen,et al.  Cloning and functional expression of a human heparanase gene. , 1999, Biochemical and biophysical research communications.

[73]  W. Cowden,et al.  Differential effects of the anti‐inflammatory compounds heparin, mannose‐6‐phosphate, and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells, and platelets , 1995, Journal of leukocyte biology.

[74]  P. Scuderi,et al.  Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. , 1991, Cellular immunology.

[75]  A. Skubitz,et al.  Laminin Peptide Ameliorates Brain Injury by Inhibiting Leukocyte Accumulation in a Rat Model of Transient Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[76]  D. Taub,et al.  Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. , 1996, Journal of immunology.

[77]  R. Baker,et al.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis , 1999, Nature Medicine.

[78]  Z. Werb,et al.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression , 1989, The Journal of cell biology.

[79]  A. Lander,et al.  Differential binding of chemokines to glycosaminoglycan subpopulations , 1994, Current Biology.

[80]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[81]  Z. Werb,et al.  Proteinases and extracellular matrix remodeling. , 1989, Current opinion in cell biology.

[82]  Gary R. Grotendorst,et al.  Two peptides related to platelet-derived growth factor are present in human wound fluid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Hauser,et al.  Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.

[84]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  E. Waubant,et al.  T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.

[86]  M. Denis,et al.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. , 1993, American journal of respiratory cell and molecular biology.

[87]  R. Hershkoviz,et al.  Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity. , 1995, Journal of autoimmunity.

[88]  E. Appella,et al.  A urokinase‐sensitive region of the human urokinase receptor is responsible for its chemotactic activity , 1997, The EMBO journal.

[89]  A. H. Drummond,et al.  Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.

[90]  M. Cuzner,et al.  Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.

[91]  R. Clark,et al.  Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation. , 1990, The Journal of clinical investigation.

[92]  R. Hershkoviz,et al.  Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. , 1994, Journal of immunology.

[93]  D. Waltz,et al.  Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. , 1994, The Journal of biological chemistry.

[94]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[95]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  A. Sahni,et al.  Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin* , 1998, The Journal of Biological Chemistry.

[97]  T. Stephenson,et al.  Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. , 1997, Journal of immunology.

[98]  I. Cohen,et al.  Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. , 1992, Invasion & metastasis.

[99]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[100]  I. Cohen,et al.  Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents. , 1997, International immunology.

[101]  L. Sporn,et al.  Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices. , 1997, Blood.

[102]  H. Zhou,et al.  Induction of metalloproteinase activity in human T-lymphocytes. , 1993, Biochimica et biophysica acta.

[103]  I. Cohen,et al.  A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[104]  C. Parish,et al.  Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour‐cell‐derived heparanases , 1987, International journal of cancer.

[105]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[106]  N. Hooper,et al.  Membrane protein secretases. , 1997, The Biochemical journal.

[107]  T. Springer,et al.  The C–C Chemokine MCP-1 Differentially Modulates the Avidity of β1 and β2 Integrins on T Lymphocytes , 1996 .

[108]  Gary R. Grotendorst,et al.  Leukocyte‐derived growth factor links the PDGF and CXC chemokine families of peptides , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  S. Strickland,et al.  Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. , 1986, Biochemistry.

[110]  H. Spring,et al.  Urokinase‐type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix , 1994, Journal of leukocyte biology.

[111]  S. Chandler,et al.  Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview , 1997, Journal of Neuroimmunology.

[112]  S. Roman-Roman,et al.  A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. , 1997, Cytokine.

[113]  J. Gallin Neutrophil specific granules: a fuse that ignites the inflammatory response. , 1984, Clinical research.

[114]  F. Blasi uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? , 1997, Immunology today.

[115]  L. Lyford,et al.  Elastase is a constituent product of T cells. , 1991, Biochemical and biophysical research communications.

[116]  R. Black,et al.  The proteolytic activation of interleukin-1 beta. , 1991, Agents and actions. Supplements.

[117]  S. Wahl,et al.  Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. , 1994, The Journal of clinical investigation.